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BACKGROUND: Nasopharyngeal carcinoma is one of the rare 
forms of cancer globally which has a high incidence in select 
geographic and ethnic populations. The current study aims to 
assess the clinical presentation, imaging patterns and radiology-
pathology correlation of nasopharyngeal carcinoma. 
METHODS: This is a retrospective analysis of 80 patients with 
newly diagnosed nasopharyngeal carcinoma who came to Tikur 
Anbessa Specialized Hospital from January 2016 to August 2017. 
The patients’ history, physical examination, abdominopelvic 
ultrasound, chest x-ray, computed tomography scan and biopsy 
reports were reviewed from their medical record. Patients who had 
previous history of treatment for nasopharyngeal carcinoma, those 
who did not have biopsy and those without imaging were excluded 
from the study. 
RESULTS: This study showed that 61(81.3%) patients had neck 
swelling as the initial clinical symptom, and the average time of 
presentation of symptoms was 6(IQR 8) months. On the other 
hand, 56(70.0%) were diagnosed with non-keratinizing 
undifferentiated nasopharyngeal carcinoma while 15(3.8%) had 
keratinizing nasopharyngeal carcinoma. Sixty-nine (86.3%) 
patients had nodal metastasis; 22.5% had invasion into the 
paranasal sinuses; 47.5% had T4 with T1, T2 and T3 being 18.8%, 
17.5% and 7.5% stage respectively at time of diagnosis. Ninety 
percent of the cases had a diagnosis of nasopharyngeal carcinoma 
on imaging, but 10% were given alternative diagnosis. 
CONCLUSION: Non-keratinizing undifferentiated type was the 
commonest histologic subtype in this study which is also recognized 
as the commonest one in endemic countries. A significant number 
did not have a specific histologic WHO type on pathology report 
which could in turn affect the management and assessment of risk 
factors.   
KEYWORDS: Nasopharyngeal carcinoma, CT imaging pattern, 
Histopathology  
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Nasopharyngeal carcinoma (NPC) is a cancer that 
arises from the nasopharynx epithelium with the 
epicenter of the mass at the fossa of Rosenmüller 
(1). The clinical behavior, epidemiology, and 
histopathology are different from that of squamous 
cell carcinomas of the head and neck (1,2).  
On the basis of the World Health Organization 
(WHO) classification, NPC is classified into three 
pathological subtypes. Keratinizing squamous cell 
carcinoma (formerly WHO type I), non-
keratinizing carcinoma which is further 
subclassified as differentiated and undifferentiated 
(formerly WHO Type II and III). The final subtype 
is Basaloid squamous cell carcinoma (3).  
There are increased risks associated with 
certain foods eaten within high-risk areas, such as 
salted fish, certain preserved foods, and hot spices, 
which are high in nitrosamine compounds and 
volatile nitrosamines (4). Patients present with 
local and non-specific symptoms, such as neck 
swelling and epistaxis, depending on the route of 
spread and anatomic structures affected including 
hearing loss, otalgia, headache, or cranial nerve 
palsy (1,2). 
Because of the location of the disease, non-
specific clinical presentation and  the difficulty to 
do clinical examination of the nasopharynx, 
patients are often misdiagnosed and present with 
advanced stage (5,6). Computed tomography (CT) 
and Magnetic resonance imaging (MRI) are the 
recommended imaging modalities of choice (1,7). 
The tumor, node and metastasis (TNM) 
classification of the American Joint Committee on 
Cancer (AJCC) 7th is used to determine the tumor 
staging. A definitive diagnosis of NPC needs a 
positive biopsy, and the role of imaging is for 
staging purposes. As to our knowledge, there is no 
study done on NPC in Ethiopia, and the burden of 
the disease is not known. The intention of this 
study is to assess the clinical presentation, imaging 





The study was conducted from January 2016 to 
August 2017 at Tikur Anbessa Specialized Hospital 
(TASH), Addis Ababa, Ethiopia. It is a tertiary 
hospital and the only cancer center that provides 
radiotherapy for its patients. The Department of 
Radiology in the hospital has advanced imaging 
modalities, such as a 1.5T magnetic resonance 
imaging (MRI), a 128 and 64 slice computed 
tomography (CT) machines. This was a 
retrospective study conducted by reviewing the 
medical records of all newly diagnosed, untreated 
nasopharyngeal carcinoma patients who came to 
the oncology department at TASH.  The medical 
records of 92 patients were reviewed, 4 were 
mislabeled as NPC and 8 had incomplete data 
leaving 80 patients. The patients’ history, physical 
examination, abdominopelvic ultrasound, chest x-
ray, computed tomography scan and biopsy reports 
were reviewed by the principal investigator. 
Patients who had previous history of treatment for 
NPC, those who did not have biopsy and those 
without imaging were excluded from the study.  
The biopsy was taken from the primary 
nasopharyngeal lesion or from involved neck 
lymph nodes. The reviewed CT scans were from 
TASH as well as private institutions. All data were 
recorded on a structured questionnaire. The 
patients’ imaging reports were analyzed and 
restaged according to the American Joint 
Committee on Cancer (AJCC) 7th edition for 
nasopharyngeal carcinoma(3). Patients who did not 
have CT, biopsy or had incomplete medicals record 
were excluded from the study. 
Ethical consideration: Ethical approval was 
obtained from the Ethics Committee of the 
Department of Radiology before the 
commencement of the study.  
Statistical analysis: Mean and ranges were 
calculated for continuous variables.  Proportions 
and frequency tables were used to summarize 
categorical variables. Statistical analysis was done 
using statistical package for social sciences 21 
(SPSS). Fisher’s exact tests was used to assess the 
significance of association between independent 




In this study, there were a total of 80 patients; 
54(67.5%) were males while 26(32.5%) were 
females, with male-to-female ratio of 2:1. The 
mean age was 37.3 ±16.2 years ranging from 13 to 
78 years.   The age group of 21 to 30 years was 
24(30%) as shown in Figure 1. 
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Figure 1: Age group distribution of patients diagnosed with NPC at Tikur Anbessa Hospital, 
January 2016- August 2017 
 
Patients had multiple clinical presentations at the 
time of diagnosis. Neck swelling as the initial 
clinical symptoms was seen in 61(81.3%) patients 
with 19(23.8%) having bilateral and 46(57.5%) 
having unilateral neck swelling. Nasal obstruction 
was seen in 32(40%) patients and 19 had headache 
as listed in Table 2. 
 
 Table 1: Clinical Symptoms of patients diagnosed with NPC at Tikur Anbessa Hospital, January 












The average time of symptom presentation was six 
months (IQR 8) ranging from six months to 24 
months with 23.8% presenting at 12 months. 
Heterogeneous CT contrast enhancement pattern 
was seen in 40.0% of lesions while 31.3% had 
homogenous 
enhancement. In 25.0 %, the enhancement pattern 
was not specified. Skull base invasion was seen in 
47 (58.8%) and intracranial and cavernous 
extension was seen in 28 (35.0%) and 15 (18.8%) 
respectively. Invasion into the paranasal sinuses 18 
Clinical Symptoms                         Frequency (n)           Percent (%)                                  
Bilateral Neck Swelling 19 23.8 
Unilateral Neck Swelling 46 57.5 
Headache 19 23.8 
Dysphagia 6 7.5 
Nasal Obstruction 32 40 
Hearing Complaint 15 18.8 
Cranial Nerve Involvement 4 5 
Voice Change 3 3.8 
Others 19 23.8 
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cases (22.5%), the sphenoid sinus alone was 
involved in seven cases. Sphenoid sinus and/or 
additional ethmoid, maxillary and frontal sinus 
involvement was seen in five (6.3%) patients. 
Perineural spread to foramen ovale was seen in 12 
cases (15%). Perivascular spread through the 
carotid canal was seen in three patients (3.8%) as 
seen in Table 2. 
 
Table 2: Imaging findings of patients diagnosed with NPC at Tikur Anbessa Hospital January 2016- 
August 2017 
Characteristics  Frequency Percent 
CT Contrast Patterns   
Homogenous 25  31.3 
Heterogeneous 32 40 
Enhancing 3 3.8 
Not specified 20 25 
Intracranial   
  Cavernous Sinus 15 18.8 
  Middle Cranial 11 13.8 
  Posterior Cranial 6 7.5 
  Anterior Cranial 4 5.0 
Perineural Involvement   
 Foramen Ovale 12 15.0 
 Foramen Spinosum 6 7.5 
 Foramen Lacerum 9 11.3 
Hypoglossal Canal 2 2.5 
Vidian Canal 3 3.8 
 
According to the T stage, 38 patients (47.5%) had 
T4 with T1, T2 and T3 being 18.8%, 17.5% and 
7.5% respectively. In 7(8.8%) patients, staging 
could not be done. Nodal metastasis was seen in 69 
out of 80 (86.3%) patients with 42.5% having N2 
stage and 16.3% having N1 stage. In 31(38.8%) of 
patients, the nodal stage could not be assessed. 
Central necrosis of lymph nodes were  seen in 26 
patients.  The overall staging is summarized in 
Table 3.
 
Table 3: Staging of patients diagnosed with NPC at Tikur Anbessa Hospital January 2016- August 
2017. 
Variable Frequency Percent 
Staging   
Stage 1 3  3.8 
Stage 2 6 7.5 
Stage 3 13 16.3 
Stage 4A 20 25.0 
  Stage 4B 3 3.8 
  Stage 4C 8 10.0 
  Not specified 27 33.8 
Histologic Finding   
Keratinizing SCC 3 3.8 
Non-keratinizing differentiated 6 7.5 
Non-keratinizing undifferentiated 56 70.0 
NPC without histologic classification 15 18.8 
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Figure 2 is a CT image showing an example of the 
pattern of spread, involvement of the skull base and 
lymphadenopathy in one of the patients included in 
this study. Histologic diagnosis of solely 
nasopharyngeal carcinoma, without specific 
subtype was seen in 15(18.8%) patients while 65 
patients were given specific histologic diagnosis 
out of which 56(70.0%) were non-keratinizing 
undifferentiated NPC. There was distant metastasis 
to the liver in seven (8.8%), 2(2.5%) to the lungs 
and three (3.8%) to the bones. There was no 
significant association seen between clinical 
presentation duration and the TNM staging (P= 
0.38). 
 
A B   
 
C  
a) post-contrast axial CT    b) Axial bone window    c) Post contrast axial CT 
 
Figure 2 Shows Axial post contrast soft tissue and bone window CT images of a 20-year-old male patient 
with undifferentiated NPC who presented with left neck swelling, ear pain and dysphagia of 7 months’ 
duration. Left nasopharyngeal mass with extension to the parapharyngeal and masticator space (a) with 
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As to my knowledge, there is no study done on 
NPC in Ethiopia. The intention of this study is to 
assess the clinical presentation, imaging patterns 
and pathologic subtype of NPC. In this study, NPC 
was twice as more common in males than in 
females, which is consistent with data stated in the 
several papers and the global cancer statistics 
(1,4,8). The bimodal age presentation of NPC is 
not seen in this study; rather, a peak at 31 to 30 age 
group was identified.   
Most patients had multiple clinical 
presentations at the time of diagnosis with the 
commonest being neck swelling which is in line 
with several researches done by Parsad et-al and 
Abdullah et-al (9,10). Nasal obstruction and 
headache were common, which is consistent with 
other researches where the clinical presentation is 
often a combination of the presence of mass, 
dysfunction caused by eustachian tube, skull base 
erosion and upper neck mass as described by Wei, 
W.I. (1,5) .  
A delay in presentation seen in our patients 
has also been mentioned by Prasad et-al with 
several contributing factors ranging from lack of 
awareness by both patients and consulted 
physicians as well as the non-specific symptoms 
contributing to late presentation to health facilities 
as stated by Wei et-al (5,6,9). This is even more 
complicated in Ethiopia where Tuberculosis (TB) 
is endemic and cervical lymph node is the 
commonest site to be involved in TB lymphadenitis 
causing further delay in the correct diagnosis 
(11,12).  
According to the T stage, the majority had T4 
in our study, and T3 was significantly lower. T-
staging could not be done for a significant number 
of cases because of lack of adequate information on 
CT reports. This in turn plays a substantial role in 
the T staging as well as overall staging which could 
explain why the T3 stage in this study was much 
lower compared to findings reported elsewhere. 
This inaccurate staging in turn will affect the 
patient management and assessment of interval 
change on imaging once treatment is started. The 
treatment plan changes once a tumor is designated 
as T2 (or more) and not T1, as adjuvant 
chemotherapy is added to the treatment regimen 
(13). 
A significant number of patients had nodal 
metastasis. In approximately one third of patients, 
the nodal stage could not be assessed which also 
compromised the staging because of inadequate 
information on imaging reports. The evaluation of 
the status of lymph nodes is extremely important 
and physical examination alone is said to be 
inaccurate (12).  The histologic status of a lymph 
node on CT by using criteria such as central 
necrosis or node size larger than 1 cm has been 
shown to be dependable (14).  
Skull base invasion was common and was 
seen in over half the cases and overall intracranial 
extension was higher compared to research done by 
Sham et-al. The intracranial extension to the 
middle cranial fossa was comparable with Sham et-
al (15). Paranasal sinus invasion in our study was 
in line with research done by Li Tian et al (16) with 
the frequently involved sinus being the sphenoid 
sinus. 
Perineural spread especially through foramen 
ovale was the commonest finding. The commonest 
WHO subtype was non-keratinizing 
undifferentiated NPC.  There were only a few cases 
of keratinizing differentiated type in this study. As 
stated by Glastonbury et-al, non-keratinizing NPC 
is said to be the most common form, approximately 
75%,  with undifferentiated type being around 4 
times more common than differentiated type (13). 
 This was also reported by BS Alabi et al 
where 70% were non-keratinizing undifferentiated 
subtype in Ilorin, Nigeria (17). This histologic type 
of NPC is commonly associated with tumors found 
in endemic countries. These findings are consistent 
with our study.  Pathology reports stated simply as 
NPC as the final diagnosis without specific subtype 
is not the reporting format recommended by WHO. 
This could potentially mean that a larger number of 
patients could have non-keratinizing 
undifferentiated nasopharyngeal carcinoma raising 
the question of whether it is endemic in Ethiopia. 
This is a daunting piece of information as a great 
deal is being done where NPC is endemic in terms 
of possible screening, treatment modality and 
follow-up for a better outcome in these patients.  
Although biopsy is the gold standard to make 
a diagnosis, imaging can recommend a different 
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differential diagnosis particularly based on the site 
of origin of the lesion. Nasopharyngeal carcinoma 
is a cancer that arises from the nasopharynx 
epithelium with the epicenter of the mass at the 
fossa of Rosenmüller. Possible differential 
diagnosis of malignant tumors of the nasopharynx 
includes lymphoma, extramedullary plasmacytoma, 
adenoid cystic carcinoma, melanoma and 
rhabdomyosarcoma (1). 
The limitation of this study was that this was a 
retrospective study; therefore, there was no control 
over the amount of information that could be 
gathered. Epstein Barr virus (EBV) has been 
studied as an etiologic factor, especially in the 
endemic type, and is considered an important step 
in NPC progression (18).  There was no Epstein 
Barr virus (EBV) detection done in this study, 
which would have further strengthened the ability 
to assess if there is any correlation  between EBV 
and NPC in Ethiopia. The biopsy was taken from 
lymph nodes or the nasopharyngeal mass rather 
than the recommended biopsy from the 
nasopharyngeal mass itself. The pathology reports 
did not follow WHO regulations. 
In conclusion, nasopharyngeal carcinoma is an 
important form of cancer that emphasis should be 
put on in Ethiopia. The commonest presentation 
was cervical lymphadenopathy with advanced 
stage. Non-keratinizing undifferentiated type was 
the commonest histology raising the possibility that 
NPC could be endemic in Ethiopia. A substantial 
number did not have a specific histologic WHO 
sub-type on pathology report. 
It is the recommendation of this study that 
radiologists need to report their imaging findings 
with staging done according to AJCC, and 
pathologists should use the standard WHO 
classification in their reports.  TB is endemic in 
Ethiopia, but it is important to differentiate TB 
lymphadenitis from metastatic lymphadenopathy in 
order to prevent delay in diagnosis of NPC.  This 
study shows that the histologic type is one that is 
found in endemic regions. We recommend that a 
prospective study be conducted to determine the 
possible causes and risk factors for NPC in the 
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